Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and Novo Nordisk announced the establishment of an international postdoctoral fellowship programme to support research within the fields of diabetes, metabolism and endocrinology. A total of 12 postdoctoral fellowships will be awarded, each for a 3 year period. The fellows will be hosted by Oxford University and funded by Novo Nordisk. The goal of the new programme is to support the development of a new generation of research leaders while further developing scientific excellence within diabetes.

Logo of Novo Nordisk (University of Oxford).

The programme will be coordinated through the Radcliffe Department of Medicine (RDM). The first four fellows in the programme will start in the autumn of 2014. Full details on the programme will be available shortly on the RDM website. Any enquiries should be directed to Dr Ruth McCaffrey.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Professor Hugh Watkins wins £30 million research award to cure killer heart diseases

The British Heart Foundation award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine.

Six RDM research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Ewa Gogola receives Wellcome Early Career Award

Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project ‘DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?’